Surgalign Holdings Inc
F:RT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Surgalign Holdings Inc
Total Liabilities & Equity
Surgalign Holdings Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Surgalign Holdings Inc
F:RT2
|
Total Liabilities & Equity
$67.7m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-12%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Total Liabilities & Equity
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
6%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Total Liabilities & Equity
$4.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Liabilities & Equity
$6.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Liabilities & Equity
$2.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
25%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Liabilities & Equity
$2.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
What is Surgalign Holdings Inc's Total Liabilities & Equity?
Total Liabilities & Equity
67.7m
USD
Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Total Liabilities & Equity amounts to 67.7m USD.
What is Surgalign Holdings Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-12%
Over the last year, the Total Liabilities & Equity growth was -44%. The average annual Total Liabilities & Equity growth rates for Surgalign Holdings Inc have been -42% over the past three years , -28% over the past five years , and -12% over the past ten years .